Latest Period
Q2 2026
Security Snapshot
Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PCSA) Institutional Ownership
CUSIP: 74275C403
13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026
Institutions Reporting
12
Shares (Excl. Options)
255,549
Price
$1.92
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- PCSA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 255,549
- Total 13F value
- $498,316
- Portfolio coverage rank
- 0%
- Share change
- +77,843
- Value change
- +$157,111
- Number of holders
- 12
- Shares outstanding
- 2,774,879
- SEC-reported price per share
- $2.56
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PCSA - Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 74275C403.
- 12 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 10 to 12 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $448,464 to $498,316.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 12 institutions filings for Q2 2026.
Security key
74275C403
Latest holder period
Q2 2026
13F holders
12
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
PCSA full holder history
Processa Pharmaceuticals, Inc. SEC filings
Processa Pharmaceuticals, Inc. company facts
Processa Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74275C403:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
PCSA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Chiliz Group Ltd. | 13% | $959,722 | 305,644 | HX Entertainment Ltd | 13 Feb 2026 | |||
| INTRACOASTAL CAPITAL, LLC | 8.1% | $644,000 | 200,000 | Mitchell P. Kopin | 31 Dec 2025 | |||
| Soleus Capital Master Fund, L.P. | 5.8% | $328,324 | 160,943 | Soleus Capital Master Fund, L.P. | 03 Aug 2026 |
As of 30 Jun 2026, 12 institutional investors reported holding 255,549 shares of Processa Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PCSA). This represents 9.2% of the company’s total 2,774,879 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q2 2026
Rows shown
1-3 of 3